Oncostatin M Receptor (OSMR) Peptide
OSMR
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all Oncostatin M Receptor (OSMR) products
- Oncostatin M Receptor (OSMR)
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- YQSEVLAERL PLTPVSLKVS TNSTRQSLHL QWTVHNLPYH QELKMVFQIQ
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of OSMR antibody,
Alternative Names: OSMR control peptide, OSMR antibody Blocking Peptide, Anti-OSMR Blocking Peptide, Oncostatin M Receptor Blocking Peptide, MGC150626 Blocking Peptide, MGC150627 Blocking Peptide, MGC75127 Blocking Peptide, OSMRB Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- Oncostatin M Receptor (OSMR)
- Synonyms
- OSMRB Peptide, PLCA1 Peptide, oncostatin M receptor Peptide, OSMR Peptide, Osmr Peptide
- Background
- Oncostatin M is a member of the IL6 family of cytokines. Functional receptors for IL6 family cytokines are multisubunit complexes involving members of the hematopoietin receptor superfamily. Many IL6 cytokines utilize gp130 as a common receptor subunit. OSM binds to the gp130 receptor subunit and, in association with the leukemia inhibitory factor receptor, induces a proliferative response in permissive cells.
- Molecular Weight
- 110 kDa
-
You are here:
